Design Therapeutics Inc

NASDAQ DSGN

Data sourced from iex and EODHD
Download Data

Design Therapeutics Inc Income Statement 2019 - 2023

This table shows the Income Statement for Design Therapeutics Inc going from 2019 until 2023. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Revenue
M 0 0 0 0 1
Cost of Revenue
M 1 0 0 0 -
Gross Profit
M -1 0 0 0 -
Operating Expenses
M 78 67 36 8 -
Selling, General, and Administrative Expenses (SG&A)
M 21 19 11 2 1
Research and Development (R&D) Expenses
M 57 49 25 6 2
Other Operating Expenses
M -1 0 0 0 -
Costs and Expenses
M 78 67 36 8 -
Operating Income
M -78 -68 -36 -8 -2
Interest Expense
M - 5 0 0 0
Non-operating Income/Expense
M 11 4 0 0 0
EBT
M -67 -63 -36 -8 -2
Income Tax Provision
M -1 -5 0 0 0
Income after Tax
M -66 -59 -35 -8 -2
Non-Controlling Interest
M - 0 0 0 0
Net Income
M - -63 -36 -8 -2
Shares (Basic, Weighted)
M - - - - -
Shares (Diluted, Weighted)
R 55,980,000.00 55,707,517.00 45,940,000.00 27,190,000.00 27,193,045.00
EBITDA
M -78 -67 -36 -8 -2
Depreciation and Amortization
M 1 0 0 0 -
EBIT
M -79 -68 -36 -8 -2
Income from Discontinued Operations
M - - - - -
Tax Rate (Effective)
% 0.80 7.41 0.84 0.60 -6.79
Earnings Per Share (EPS), Basic
M - - - - -
Earnings Per Share (EPS), Diluted
M - 0 0 0 0
Gross Profit Margin
% - - - -2,112.39 -
Operating Income Margin
% - - - -3,685,840.71 -228.78
Net Income Margin
% - - - -3,663,716.81 -245.44
EBITDA Ratio
% - - - -3,683,628.32 -228.78
EBIT Ratio
% - - - -3,685,840.71 -228.78
EBT Ratio
% - - - -3,663,716.81 -245.44

StockViz Staff

September 19, 2024

Any question? Send us an email